T. Rowe Price Associates
RDY icon

T. Rowe Price Associates’s Dr. Reddy's Laboratories RDY Stock Holding History

T. Rowe Price Associates’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-297,775
Closed -$2.51M – 2582
2017
Q2 		$2.51M Hold
297,775
– – ﹤0.01% 1510
2017
Q1 		$2.39M Buy
297,775
+74,430
+33% +$643K ﹤0.01% 1533
2016
Q4 		$2.02M Sell
223,345
-29,400
-12% -$274K ﹤0.01% 1563
2016
Q3 		$2.35M Buy
252,745
+46,550
+23% +$444K ﹤0.01% 1515
2016
Q2 		$2.11M Buy
206,195
+69,815
+51% +$640K ﹤0.01% 1511
2016
Q1 		$1.23M Sell
136,380
-4,495
-3% -$40.2K ﹤0.01% 1648
2015
Q4 		$1.3M Sell
140,875
-80,760
-36% -$884K ﹤0.01% 1621
2015
Q3 		$2.83M Sell
221,635
-56,465
-20% -$701K ﹤0.01% 1512
2015
Q2 		$3.08M Sell
278,100
-38,660
-12% -$427K ﹤0.01% 1531
2015
Q1 		$3.62M Sell
316,760
-516,135
-62% -$5.47M ﹤0.01% 1511
2014
Q4 		$8.4M Sell
832,895
-96,515
-10% -$1.02M ﹤0.01% 1363
2014
Q3 		$9.77M Buy
929,410
+94,380
+11% +$887K ﹤0.01% 1316
2014
Q2 		$7.21M Buy
835,030
+79,915
+11% +$672K ﹤0.01% 1386
2014
Q1 		$6.63M Buy
755,115
+675
+0.1% +$5.87K ﹤0.01% 1383
2013
Q4 		$6.19M Sell
754,440
-433,650
-36% -$3.43M ﹤0.01% 1394
2013
Q3 		$8.98M Sell
1,188,090
-795,530
-40% -$5.79M ﹤0.01% 1299
2013
Q2 		$15M Buy
+1,983,620
New +$14.5M ﹤0.01% 1151

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

T. Rowe Price Associates's RDY Position: Q3 2017 in Review

T. Rowe Price Associates sold out of Dr. Reddy's Laboratories (RDY) in Q3 2017, closing a stake of 297,775 shares — an estimated $2.51M sold.

T. Rowe Price Associates first reported a position in RDY in Q2 2013 and held it in 17 quarters. The position peaked at $15M in Q2 2013. 118 funds tracked by Wall St. Rank hold RDY as of Q3 2017.

  • T. Rowe Price Associates reported no remaining Dr. Reddy's Laboratories position as of Q3 2017 after selling out during the quarter.
  • T. Rowe Price Associates sold 297,775 Dr. Reddy's Laboratories shares in Q3 2017, an estimated $2.51M.
  • T. Rowe Price Associates first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 17 quarters.
  • T. Rowe Price Associates's Dr. Reddy's Laboratories position peaked at $15M in Q2 2013.
  • 118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2017.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.